ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.090
+0.150 (5.10%)
At close: Aug 13, 2025, 4:00 PM
3.090
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $347.62 million as of August 13, 2025. Its market cap has decreased by -0.48% in one year.
Market Cap
347.62M
Enterprise Value
533.83M
1-Year Change
-0.48%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $347.62M, a decrease of -82.98%. That is a compound annual growth rate of -28.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 330.75M | 71.90% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 587.01B |
| Johnson & Johnson | 418.75B |
| AbbVie | 355.63B |
| UnitedHealth Group | 244.08B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 226.43B |
| Novo Nordisk | 223.00B |